Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / S&P BIOTECH
-
Total 13F shares
-
2,292,194
-
Share change
-
+322,439
-
Total reported value
-
$279,444,175
-
Price per share
-
$121.93
-
Number of holders
-
136
-
Value change
-
+$43,482,857
-
Number of buys
-
74
-
Number of sells
-
44
Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q4 2025
As of 31 Dec 2025,
SPDR SERIES TRUST - S&P BIOTECH (XBI) was held by
136 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,292,194 shares.
The largest 10 holders included
SG Americas Securities, LLC, Sivik Global Healthcare LLC, Allspring Global Investments Holdings, LLC, WEATHERLY ASSET MANAGEMENT L. P., Royal Fund Management, LLC, Madrona Financial Services, LLC, Edge Wealth Management LLC, WEALTH ENHANCEMENT ADVISORY SERVICES, LLC, Spire Wealth Management, and Marotta Asset Management.
This page lists
136
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.